Risk Revolution

By: Risk Revolution
Listen for free

  • Summary

  • Welcome to Risk Revolution! The goal of this series is to advance the maturity of risk management practices within the industry, by covering topics that challenge quality professionals to seek opportunities to improve and advance the ways in which they perceive and manage risk. The hosts for this series are Nuala Calnan, Valerie Mulholland, and Lori Richter.
    Show more Show less
Economics Science
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • 17: Risk Tolerance & Risk Acceptance

    17: Risk Tolerance & Risk Acceptance
    Nov 13 2022
    This episode originally aired on March 15th, 2022

    This week, series coordinator Nuala is joined once again by Risk Revolution co-hosts, Valerie Mulholland and Lori Richter with another old friend of the IVT network, Dr. James Vesper. Dr. Vesper will share his unique insights and deep learning on a very interesting aspect of RBDM, Risk Appetite, and the distinction between that and Risk Tolerance. 

    About Our Guest:
    James Vesper, MPH, Ph.D. established and is president LearningPlus, Inc., and has had more than 30 years experience in the pharmaceutical industry, including 11 years at Eli Lilly and Company. Dr. Vesper worked eleven years at Eli Lilly and Company, Indianapolis. Since 1991, he and his firm, LearningPlus, have worked with pharma/biopharma, device, and blood products organizations around the world consulting on risk management, performance solutions, and custom GMP learning events. He has been a special advisor/consultant to the World Health Organization’s (WHO) Vaccine Quality Network – Global Learning Opportunities working as a mentor and instructor for a number of different learning courses. Dr. Vesper has written five books, including Risk Assessment and Risk Management: Clear and Simple, and multiple technical articles. He has a BS in biology (Wheaton College), an MPH (University of Michigan School of Public Health), and a Ph.D. in Education from Murdoch University in Perth, Western Australia. Dr. Vesper may be contacted at jvesper@learningplus.com.
    Show more Show less
    48 mins
  • 16: ICH Q9 Revision, Is It Enough?

    16: ICH Q9 Revision, Is It Enough?
    Nov 13 2022
    This episode originally aired on February 15th, 2022

    In this episode, Nuala Calnan and Valerie Mulholland discuss the ICH Q9 Revision with Kate Coleman of PharmaLex. The revisions were released for public consultation in November and are an improvement over the existing guidance but do leave a few areas that need to be explored further.

    Resources from this episode:
    ICH Q9 Quality Risk Management Revision - https://www.ivtnetwork.com/article/ich-q9-quality-risk-management-revision
    Link to the new guidance - https://database.ich.org/sites/default/files/ICH_Q9-R1_Document_Step2_Guideline_2021_1118.pdf
    Understanding the Concept of Formality In Quality Risk ... - https://www.ivtnetwork.com/article/understanding-concept-formality-quality-risk-management
    Risk Management, Knowledge Management and the Risk Knowledge Infinity Cycle on Risk Revolution - https://www.ivtnetwork.com/article/risk-management-knowledge-management-and-risk-knowledge-infinity-cycle-risk-revolution
    Can ‘Fuzzy Logic’ Be Applied To Risk Management In Pharmaceuticals And Healthcare? - https://www.ivtnetwork.com/article/can-%E2%80%98fuzzy-logic%E2%80%99-be-applied-risk-management-pharmaceuticals-and-healthcare-risk-revolution

    About Our Guest:
    Kate Coleman
    Kate has worked in Quality roles in the Pharma Industry up to management level for 19 years, covering several platforms including Biologics, Sterile Fill Finish, Vaccines, and Oral Dose. Kate is a practicing QP, Principal Consultant, a qualified Lead Auditor, and an SME in Risk Management, New Facility Design/Start-Up, QC, and Sterility Assurance.
    Show more Show less
    57 mins
  • 15: Foundations in Quality Risk Management w/Dr. Tim Sandle

    15: Foundations in Quality Risk Management w/Dr. Tim Sandle
    Nov 13 2022
    This episode was originally aired on Decomber 21st, 2021

    In this episode, Nuala Calnan and Valerie Mulholland discuss the book "Foundations in Quality Risk Management" with the author, Dr. Tim Sandle. One of the key topics of discussion is dealing with "Fuzzy Logic", and how to manage situations that appear vague, and how that applies to the Pharmaceutical and Healthcare industries.

    Resources from this episode:
    The ICH Q9 (R1) Guidelines - https://www.dropbox.com/s/1xhsv2v0l2wumd2/ICH_Q9-R1_Documehttps:/www.dropbox.com/s/1xhsv2v0l2wumd2/ICH_Q9-R1_Document_Step2_Guideline_2021_1118.pdf?dl=0nt_Step2_Guideline_2021_1118.pdf?dl=0
    ICH Q9 (R1) Presentation - https://www.dropbox.com/s/23loupxxij00pc3/Published%20ICH_Q9%28R1%29_Step_2_Presentation_2021_1126.pdf?dl=0
    Can Fuzzy Logic Be Applied to Risk Management - https://www.ivtnetwork.com/article/can-%E2%80%98fuzzy-logic%E2%80%99-be-applied-risk-management-pharmaceuticals-and-healthcare
    Critical Thinking #1: Why Pharmaceuticals and Healthcare Needs - https://www.ivtnetwork.com/article/critical-thinking-1-why-pharmaceuticals-and-healthcare-needs-more-critical-thinkers
    Critical Thinking #2: Reading Research Papers - https://www.ivtnetwork.com/article/critical-thinking-2-reading-research-papers
    Critical Thinking #3: Developing Questions to Achieve the Optimal - https://www.ivtnetwork.com/article/critical-thinking-3-developing-questions-achieve-optimal-outcome
    Risk Management, Knowledge Management and the Risk Knowledge Infinity Cycle on Risk Revolution - https://www.ivtnetwork.com/article/risk-management-knowledge-management-and-risk-knowledge-infinity-cycle-risk-revolution
    Risk Revolution - Getting to the Root of the Matter - http://www.ivtnetwork.com/article/getting-root-matter-risk-revolution-0
    Show more Show less
    52 mins

What listeners say about Risk Revolution

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available